Successful treatment with rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low‐grade non‐Hodgkin's lymphoma
Open Access
- 29 May 2001
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 67 (3) , 213-214
- https://doi.org/10.1002/ajh.1112
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic Graft-versus-Host DiseaseAnnals of Internal Medicine, 2000
- Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphomaBlood, 2000
- Clonal B-cell populations in patients with idiopathic thrombocytopenic purpuraBlood, 1990
- Clonal B-cell populations in patients with idiopathic thrombocytopenic purpuraBlood, 1990
- Immune thrombocytopenia in lymphoproliferative diseasesBlood, 1979